{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:10:45Z","timestamp":1782180645677,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024808","name":"Health Innovation North East and North Cumbria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jacl.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T07:40:28Z","timestamp":1711698028000},"page":"e572-e578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0494-9381","authenticated-orcid":false,"given":"Matthew","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-244X","authenticated-orcid":false,"given":"Jon","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Stansby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8508-2209","authenticated-orcid":false,"given":"Ahai","family":"Luvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2024.03.008_bib0001","unstructured":"British Heart Foundation: Heart and circulatory disease statistics 2021 [Internet]. Available from: https:\/\/www.bhf.org.uk\/-\/media\/files\/for-professionals\/research\/heart-statistics\/bhf-statistics-compendium-2021.pdf?rev=5637cf33173a4beeaf8f776b22562e44&hash=B4067E06C2B04C363C4B531D726697AE."},{"key":"10.1016\/j.jacl.2024.03.008_sbref0002","series-title":"What is the prevalence of stroke and TIA in the UK? [Internet]","year":"2022"},{"key":"10.1016\/j.jacl.2024.03.008_bib0003","series-title":"European cardiovascular disease statistics 2017","author":"Wilkins","year":"2017"},{"key":"10.1016\/j.jacl.2024.03.008_bib0004","unstructured":"CVD risk assessment and management: what is the impact of CVD? [Internet]. 2023 [cited 2023 Aug 17]. Available from: https:\/\/cks.nice.org.uk\/topics\/cvd-risk-assessment-management\/background-information\/burden-of-cvd\/."},{"key":"10.1016\/j.jacl.2024.03.008_bib0005","unstructured":"NHS. The NHS Long Term Plan [Internet]. Nhs.uk. 2019 [cited 2023 Aug 17]. Available from: https:\/\/www.longtermplan.nhs.uk\/wp-content\/uploads\/2019\/01\/nhs-long-term-plan-june-2019.pdf."},{"key":"10.1016\/j.jacl.2024.03.008_bib0006","series-title":"European cardiovascular disease statistics 2017","author":"Wilkins","year":"2017"},{"issue":"6","key":"10.1016\/j.jacl.2024.03.008_bib0007","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7861\/clinmedicine.13-6-618","article-title":"Lipid management: maximising reduction of cardiac risk","volume":"13","author":"Webb","year":"2013","journal-title":"Clin Med [Internet]"},{"key":"10.1016\/j.jacl.2024.03.008_bib0008","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"25","key":"10.1016\/j.jacl.2024.03.008_bib0009","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacl.2024.03.008_bib0010","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"European Heart J [Internet]"},{"issue":"11","key":"10.1016\/j.jacl.2024.03.008_bib0011","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"DA VINCI study. EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2024.03.008_bib0012","unstructured":"British Heart Foundation. Our vision is a world free from the fear of heart and circulatory diseases. UK Factsheet [Internet]. 2023 Apr. Available from: https:\/\/www.bhf.org.uk\/-\/media\/files\/for-professionals\/research\/heart-statistics\/bhf-cvd-statistics-uk-factsheet.pdf."},{"issue":"3","key":"10.1016\/j.jacl.2024.03.008_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2020.04.004","article-title":"Effect of pharmacist interventions on reducing low-density lipoprotein cholesterol (LDL-C) levels: a systematic review and meta-analysis","volume":"14","author":"Dixon","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2024.03.008_bib0014","article-title":"Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9","volume":"9","author":"Khatib","year":"2022","journal-title":"inhibitors"},{"key":"10.1016\/j.jacl.2024.03.008_bib0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.avsg.2021.03.055","article-title":"Lipid optimization in lower extremity peripheral arterial disease","volume":"76","author":"Sucharitkul","year":"2021","journal-title":"Ann Vasc Surg [Internet]."},{"key":"10.1016\/j.jacl.2024.03.008_bib0016","unstructured":"Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD. 2020. Available from: https:\/\/www.england.nhs.uk\/aac\/publication\/summary-of-national-guidance-for-lipid-management\/"},{"key":"10.1016\/j.jacl.2024.03.008_bib0017","unstructured":"Northern England Evaluation and Lipid Intensification guideline [Internet] 2022 February 1. Available from: https:\/\/nescn.nhs.uk\/wp-content\/uploads\/2021\/07\/NEELI-Final-10.2.pdf."}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T23:48:47Z","timestamp":1724975327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1933287424000424"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.03.008","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}